Doctors Note Logo

Published on: 9/15/2026

Does high C-reactive protein mean I'm at risk for a heart attack or stroke?

Elevated C-reactive protein (CRP) signals inflammation in the body and, when measured with a high-sensitivity test (hs-CRP above 3 mg/L), has been linked to a higher likelihood of heart attack and stroke, though it is a marker of risk rather than proof that heart disease is present. Many other conditions raise CRP, including infections, recent injury, autoimmune disease, obesity, smoking, and even pregnancy or hormone use, so the number must be interpreted alongside cholesterol, blood pressure, blood sugar, family history, and symptoms. There are several important factors and thresholds to consider before drawing conclusions, so see below for the complete answer. Because inflammation-related cardiovascular risk often develops silently, clarifying your own picture early matters, and a free, instant online symptom check can help you connect your test results to what you are actually experiencing. It takes only a few minutes, is available anytime, and gives you clearer, more organized information to bring to a doctor so you know which next steps deserve priority.

Last reviewed for medical accuracy: 09/14/2026

answer background

Explanation

Understanding C-Reactive Protein (CRP) and Your Heart Health

C-reactive protein (c reactive protein or CRP) is a substance your liver produces when there’s inflammation in your body. Doctors use a high-sensitivity CRP (hs-CRP) blood test to measure low levels of this protein, helping assess the risk of heart attack or stroke. Below, we’ll explain what a high CRP result means, how it relates to cardiovascular risk, and what you can do next.

What Is C-Reactive Protein?

• Inflammation marker: CRP levels rise in response to inflammation anywhere in the body—caused by infections, injuries, or chronic conditions.
• Sensitive test: The hs-CRP test detects even small increases in CRP, making it useful for cardiovascular risk assessment.
• Not disease-specific: A high CRP doesn’t tell you where inflammation is or what’s causing it—it just flags that your body is fighting something.

CRP Levels and Cardiovascular Risk

According to guidelines from the American Heart Association and the Centers for Disease Control and Prevention, hs-CRP levels correspond roughly to cardiovascular risk as follows:

• Less than 1.0 mg/L: Low risk
• 1.0–3.0 mg/L: Average risk
• Greater than 3.0 mg/L: High risk

Keep in mind that these categories are general. Your overall risk depends on many factors beyond CRP alone.

Why Does High CRP Matter for Heart Attack and Stroke?

Inflammation plays a key role in atherosclerosis, the process where plaque builds up in artery walls. Over time, plaque can:

• Narrow arteries, reducing blood flow to the heart or brain
• Become unstable and rupture, leading to blood clots
• Trigger a heart attack (if a clot blocks a coronary artery) or stroke (if a clot blocks an artery in the brain)

A persistently high level of c reactive protein suggests ongoing inflammation, which may accelerate plaque formation and instability.

Interpreting Your CRP Test in Context

CRP is just one piece of the puzzle. Your doctor will consider:

• Blood pressure
• Cholesterol levels (LDL, HDL, triglycerides)
• Blood sugar or A1C (for diabetes risk)
• Body mass index (BMI) and waist circumference
• Smoking status
• Family history of heart disease or stroke
• Physical activity level

Combining these factors provides a more accurate picture of your cardiovascular risk than CRP alone.

Common Causes of Elevated CRP

• Acute infections (viral or bacterial)
• Chronic inflammatory conditions (arthritis, lupus)
• Obesity, especially excess belly fat
• Smoking or heavy alcohol use
• Poor sleep or chronic stress
• Certain cancers

If an infection or flare-up of a chronic illness is driving up your CRP, it may fall back to normal once the issue resolves.

Reducing Inflammation and Lowering CRP

Adopting healthy habits can lower your c reactive protein and benefit your heart:

• Eat an anti-inflammatory diet
– Plenty of fruits, vegetables, whole grains
– Fatty fish (salmon, mackerel), nuts, olive oil
– Limit processed foods, sugary drinks and snacks
• Exercise regularly
– Aim for at least 150 minutes of moderate-intensity aerobic activity per week
– Include strength training twice a week
• Achieve and maintain a healthy weight
• Quit smoking and limit alcohol intake
• Manage stress
– Mindfulness, yoga or meditation can help
– Prioritize sleep: 7–9 hours per night for adults

Medications That Can Influence CRP

Some drugs used to lower cardiovascular risk also reduce CRP levels:

• Statins: Primarily used to lower LDL cholesterol, statins also have anti-inflammatory effects.
• Aspirin: Low-dose aspirin may slightly reduce CRP but is mainly used to prevent blood clots.
• Certain anti-inflammatory agents: In specific cases (for example, rheumatoid arthritis), your specialist may prescribe targeted therapy that also impacts CRP.

Always discuss medication changes with your doctor. They’ll weigh benefits and risks based on your individual health profile.

When to Be Concerned

A single elevated CRP result isn’t an emergency. However, be mindful if you experience:

• Chest pain or discomfort, especially with sweating, nausea or shortness of breath
• Sudden weakness, numbness or difficulty speaking (possible stroke signs)
• Unexplained fever, prolonged fatigue or weight loss

For any symptom that feels serious or life-threatening, seek medical attention immediately or call emergency services.

Next Steps and Ongoing Monitoring

  1. Repeat testing: Your doctor may order a second hs-CRP test after your body has had time to recover from any acute illness.
  2. Full cardiovascular risk assessment: Incorporate CRP results with blood pressure, cholesterol and other labs.
  3. Personalized plan: Work with your healthcare team to set targets and track progress.
  4. Regular check-ups: Keep appointments for blood work and health screenings.

Consider a Free Symptom Check

If you’re unsure whether your symptoms warrant a doctor visit, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help clarify next steps and whether you should seek in-person care.

Key Takeaways

• CRP is a marker of inflammation—not a disease itself.
• High hs-CRP is linked to increased risk of heart attack and stroke, but it’s not the only factor.
• Lifestyle changes (diet, exercise, smoking cessation) can lower CRP and improve heart health.
• Medications like statins also reduce CRP in addition to other cardiovascular benefits.
• Always interpret CRP results alongside other risk factors.
• For any severe or life-threatening symptoms, seek medical care immediately.

Speak to Your Doctor

If you have concerns about your c reactive protein level, heart attack risk, or any serious symptoms, please speak to a doctor. Only a qualified healthcare provider can offer personalized advice and develop a treatment plan tailored to your needs.

(References)

  • * Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008 Apr 14;168(7):713-20. doi: 10.1001/archinte.168.7.713. PMID: 18413553.

  • * Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. PMID: 18997196.

  • * Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. PMID: 28845751.

  • * Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ, CIRT Investigators. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10. PMID: 30415610; PMCID: PMC6587584.

  • * Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, Pinto FJ, Ibrahim R, Gamra H, Kiwan GS, Berry C, López-Sendón J, Ostadal P, Koenig W, Angoulvant D, Grégoire JC, Lavoie MA, Dubé MP, Rhainds D, Provencher M, Blondeau L, Orfanos A, L'Allier PL, Guertin MC, Roubille F. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16. PMID: 31733140.

  • * Jin A, Wang S, Li J, Wang M, Lin J, Li H, Meng X, Wang Y, Pan Y. Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke. Stroke. 2023 Mar;54(3):759-769. doi: 10.1161/STROKEAHA.122.039542. Epub 2023 Feb 1. PMID: 36722344.

  • * Small AM, Pournamdari A, Melloni GEM, Scirica BM, Bhatt DL, Raz I, Braunwald E, Giugliano RP, Sabatine MS, Peloso GM, Marston NA, Natarajan P. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations. JAMA Cardiol. 2024 Apr 1;9(4):385-391. doi: 10.1001/jamacardio.2023.5605. PMID: 38353970; PMCID: PMC10867772.

  • * Chen J, Wu Q, Liu H, Hu W, Zhu J, Ji Z, Yin J. Predictive value of remnant cholesterol inflammatory index for stroke risk: Evidence from the China health and Retirement Longitudinal study. J Adv Res. 2025 Oct;76:543-552. doi: 10.1016/j.jare.2024.12.015. Epub 2024 Dec 12. PMID: 39674498; PMCID: PMC12793758.

  • * Wang Y, Zhang X, Liang A, Niu Y, Chen D, Du Z, Wu W, Zhang F, Wu G, Fang Y, Shang X, Zhu Z, Hu Y, Chen X, Yu H, Hu L. High-sensitivity C-reactive protein and risk of retinal artery occlusion and ischaemic stroke: a cross-cohort study. Br J Ophthalmol. 2025 Aug 20;109(9):1081-1087. doi: 10.1136/bjo-2023-325044. Epub 2025 Aug 20. PMID: 39904581; PMCID: PMC12418542.

  • * Huang X, Li C, Zeng P, Ling Y, Tan S, Bai Z, Shen S, Chen S, Nie B, Wang H, Lyu J. Non-traditional lipid-inflammatory parameters estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study. J Adv Res. 2026 Aug;86:337-349. doi: 10.1016/j.jare.2025.11.029. Epub 2025 Nov 17. PMID: 41260379; PMCID: PMC13453658.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.